JAK1 inhibitor (unspecified in provided data)

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JAK1 inhibitor (unspecified in provided data), covering 2021-06-04 to 2021-06-04. Get the full timeline:

Most recent: Clinical Trial Update: JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis [Phase 3]